- Breast Cancer
- Cancer Control
- Chemotherapy
- Diagnostics and Screening
- Gastrointestinal Cancers
- Genitourinary Cancers
- Geriatric Oncology
- Gynecological Oncology
- Head, Neck and Thyroid Cancers
- Hematology
- Hematological Malignancies
- Imaging
- Lung Cancer
- Neurological Cancers
- Pediatric Oncology
- Radiotherapy
- Sarcomas and Melanomas
- Supportive Oncology
Specialties
Fri, 2012-06-01
Thu, 2012-06-14
Thu, 2012-06-28
Latest Testimonial
"Very well done and exciting. Congratulations."
Professor of Medicine and Director
Emili Montserrat
Institute of Hematology and Oncology at the Hospital Clinic of Barcelona
Breast Cancer
- Pharmacology of Anastrozole
- 21-gene Assay Oncotype DX®
- Clinical Pharmacology of Anastrozole
- Early Breast Cancer
Pharmacology of Anastrozole
The Clinical Pharmacology of Anastrozole
Ting Bao, Michelle A Rudek
European Oncology & Haematology, 2011;7(2):106-108
21-gene Assay Oncotype DX®
Evolution of the 21-gene Assay Oncotype DX® from an Experimental Assay to an Instrument Assisting in Risk Prediction and Optimisation of Treatment Decision-making in Early Breast Cancer
Christian Jackisch, Michael Untch, Jens-Uwe Blohmer, Ulrike Nitz, Nadia Harbeck
European Oncology, 2010;6(1):36-42
Clinical Pharmacology of Anastrozole
The Clinical Pharmacology of Anastrozole
Ting Bao, Michelle A Rudek
European Oncology & Haematology, 2011;7(2):106-108
Early Breast Cancer
Evolution of the 21-gene Assay Oncotype DX® from an Experimental Assay to an Instrument Assisting in Risk Prediction and Optimisation of Treatment Decision-making in Early Breast Cancer
Christian Jackisch, Michael Untch, Jens-Uwe Blohmer, Ulrike Nitz, Nadia Harbeck
European Oncology, 2010;6(1):36-42











